Breast Cancer Drug Perjeta Shows Incredible Promise in Clinical Trials

September 29, 2014 6:07 AM

5 0

Breast Cancer Drug Perjeta Shows Incredible Promise in Clinical Trials

A drug used in the treatment of breast cancer patients has surprising and unprecedented success fighting the disease in a clinical study.

Patients treated with the drug Perjeta, manufactured by the Swiss drug maker Roche, saw an increased median survival time compared to other patients that populated the control group. The difference was dramatic, nearly sixteen months longer for those treated with Perjeta.

Also read: Paris announces plans to fight rat scourge

Read more

To category page

Loading...